Petition · Department of Health and Social Care
Fund access to GLP-1 medications through the NHS for women with PCOS
Closed
840 signatures
What the petition asks
Studies highlight the effectiveness of GLP-1 medications for women with PCOS. We think funding access to GLP-1 treatments, without restrictive BMI criteria or tier system barriers, would improve care and outcomes for these patients.
Studies reveal that women with PCOS have higher absenteeism, increased unemployment, and a greater risk of disability retirement by age 52.
Without effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.
We think early intervention is essential to reduce these long-term healthcare costs on the NHS.
Without effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.
We think early intervention is essential to reduce these long-term healthcare costs on the NHS.
Timeline
| 14 Jan 2025 | Petition opened for signatures |
| 14 Jul 2025 | Closed to new signatures |
Key facts
Signatures
840
Status
Closed
Department
Department of Health and Social Care
Opened
14 Jan 2025
Closed
14 Jul 2025
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 2 Aug 2026.